WITHDRAWN: Evidence for a relatively high proportion of DM2 mutations in a large group of Polish patients

Shara, 2006, Myotonic dystrophies type 1 and 2: a summary on current aspects, Semin Pediatr Neurol, 13, 71, 10.1016/j.spen.2006.06.002 Machuca-Tzili, 2005, Clinical and molecular aspects of the myotonic dystrophies: a review, Muscle Nerve, 32, 1, 10.1002/mus.20301 Redman, 1993, Relationship between parental trinucleotide CTG repeat length and severity of myotonic dystrophy in offspring, JAMA, 269, 1960, 10.1001/jama.1993.03500150072029 Bassez, 2004, Severe cardiac arrhythmias in young patients with myotonic dystrophy type 1, Neurology, 63, 1939, 10.1212/01.WNL.0000144343.91136.CF Arsenault, 2006, Clinical characteristics of myotonic dystrophy type 1 patients with small CTG expansions, Neurology, 66, 1248, 10.1212/01.wnl.0000208513.48550.08 Udd, 2006, 140th ENMC International Workshop: Myotonic Dystrophy DM2/PROMM and other myotonic dystrophies with guidelines on management, Neuromuscul Disord, 16, 403, 10.1016/j.nmd.2006.03.010 Udd, 2012, The myotonic dystrophies: molecular, clinical, and therapeutic challenges, Lancet Neurol, 11, 891, 10.1016/S1474-4422(12)70204-1 Meola, 2017, Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects, Neurol Sci, 38, 535, 10.1007/s10072-016-2805-5 Ricker, 1994, Proximal myotonic myopathy: a new dominant disorder with myotonia, muscle weakness and cataracts, Neurology, 44, 1448, 10.1212/WNL.44.8.1448 Bienias, 2016, Supraventricular and ventricular arrhythmias are related to the type of myotonic dystrophy but not to disease duration or neurological status, Pacing Clin Electrophysiol, 39, 959, 10.1111/pace.12924 Schoser, 2004, Sudden cardiac death in myotonic dystrophy type 2, Neurology, 63, 2402, 10.1212/01.WNL.0000147335.10783.E4 Day, 1999, Clinical and genetic characteristics of a five-generation family with a novel form of myotonic dystrophy (DM2), Neuromuscul Disord, 9, 19, 10.1016/S0960-8966(98)00094-7 Schoser, 2004, Muscle pathology in 57 patients with myotonic dystrophy type 2, Muscle Nerve, 29, 275, 10.1002/mus.10545 Nadaj-Pakleza, 2011, Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients, Folia Morphol, 70, 121 Yotova, 2005, Anatomy of a founder effect: myotonic dystrophy in Northeastern Quebec, Hum Genet, 117, 177, 10.1007/s00439-005-1298-8 Suominen, 2011, Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland, Eur J Hum Genet, 19, 776, 10.1038/ejhg.2011.23 Matsuura, 2012, Myotonic dystrophy type 2 is rare in the Japanese population, J Hum Genet, 57, 219, 10.1038/jhg.2011.152 International Myotonic Dystrophy Consortium, 2000, New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1), Neurology, 54, 1218, 10.1212/WNL.54.6.1218 Hino, 2007, Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1, Hum Mol Genet, 16, 2834, 10.1093/hmg/ddm239 Philips, 1998, Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy, Science, 280, 737, 10.1126/science.280.5364.737 Guiraud-Dogan, 2007, DM1 CTG expansions affect insulin receptor isoforms in various tissues of transgenic mice, Biochim Biophys Acta, 1772, 1183, 10.1016/j.bbadis.2007.08.004 Kino, 2009, MBNL and CELF proteins regulate alternative splicing of the skeletal muscle chloride channel CLCN1, Nucleic Acid Res, 37, 6477, 10.1093/nar/gkp681 Kalsotra, 2008, A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart, Proc Natl Acad Sci U S A, 105, 20333, 10.1073/pnas.0809045105 Liquori, 2001, Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9, Science, 293, 864, 10.1126/science.1062125 Liquori, 2003, Myotonic dystrophy type 2: human founder haplotype and evolutionary conservation of the repeat tract, Am J Hum Genet, 73, 849, 10.1086/378720 Botta, 2007, Gene expression analysis in myotonic dystrophy: indications for a common molecular pathogenic pathway in DM1 and DM2, Gene Expr, 13, 339, 10.3727/000000006781510705 Raheem, 2010, Mutant (CCTG)n expansion causes abnormal expression of zinc finger protein 9 (ZNF9) in myotonic dystrophy type 2, Am J Pathol, 177, 3025, 10.2353/ajpath.2010.100179 Harper, 2011 Udd, 2011, Myotonic dystrophy type 2 (DM2) and related disorders report of the 180th ENMC workshop including guidelines on diagnostics and management 3–5 December 2010, Naarden, The Netherlands, Neuromuscul Disord, 21, 443, 10.1016/j.nmd.2011.03.013 Kunkel, 1977, Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants, Proc Natl Acad Sci U S A, 74, 1245, 10.1073/pnas.74.3.1245 Ahmad, 1995, Modification of standard proteinase K/phenol method for DNA isolation to improve yield and purity from frozen blood, J Med Genet, 32, 129, 10.1136/jmg.32.2.129 Brook, 1992, Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member, Cell, 68, 799, 10.1016/0092-8674(92)90154-5 Warner, 1996, A general method for the detection of large CAG repeat expansions by fluorescent PCR, J Med Genet, 33, 1022, 10.1136/jmg.33.12.1022 Krysa, 2012, Rapid detection of large expansions in progressive myoclonus epilepsy type 1, myotonic dystrophy type 2 and spinocerebellar ataxia type 8, Neurol Neurochir Pol, 46, 113, 10.5114/ninp.2012.28253 Bachinski, 2003, Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect, Am J Hum Genet, 73, 835, 10.1086/378566 Fu, 1992, An unstable triplet repeat in a gene related to myotonic muscular dystrophy, Science, 6, 1256, 10.1126/science.1546326 Davies, 1992, Comparison of the myotonic dystrophy associated CTG repeat in European and Japanese populations, J Med Genet, 29, 766, 10.1136/jmg.29.11.766 Bachinski, 2009, Premutation allele pool in myotonic dystrophy type 2, Neurology, 72, 490, 10.1212/01.wnl.0000333665.01888.33 Sobczak, 2004, Patterns of CAG repeat interruptions in SCA1 and SCA2 genes in relation to repeat instability, Hum Mutat, 24, 236, 10.1002/humu.20075 Dalton, 2006, Myotonic dystrophy type 2 Saito, 2008, Myotonic dystrophy type 2 in Japan: ancestral origin distinct from Caucasian families, Neurogenetics, 9, 61, 10.1007/s10048-007-0110-4 Suominen, 2008, High frequency of co-segregating CLCN1 mutations among myotonic dystrophy type 2 patients from Finland and Germany, J Neurol, 255, 1731, 10.1007/s00415-008-0010-z Cardani, 2012, Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2, J Neurol, 259, 2090, 10.1007/s00415-012-6462-1 Sun, 2011, Myotonia congenital and myotonic dystrophy in the same family: coexistence of a CLCN1 mutation and expansion in the CNBP (ZNF9) gene, Clin Genet, 80, 574, 10.1111/j.1399-0004.2010.01616.x De Braekeler, 1991, Hereditary disorders in Saguenay-Lac-St-Jean (Quebec, Canada), Hum Hered, 41, 141, 10.1159/000153992 Novelli, 1994, North Eurasian origin of the myotonic dystrophy mutation, Hum Mutat, 4, 79, 10.1002/humu.1380040115 Goldman, 1995, Molecular analysis of the CTG trinucleotide repeat in South African myotonic dystrophy families – implications for diagnosis and counselling, S Afr Med J, 85, 1161